Phase II data presented for subcutaneous BNP in patients with preclinical diastolic dysfunction Sep. 26, 2013
Nektar Therapeutics develop a novel (PEG)-taxane conjugate with improved in vivo efficacy Sep. 26, 2013
Carboxy-terminal fragment of CPE shows potential in imaging treatment-resistant ovarian cancer Sep. 25, 2013
RSS